Irisquinone exerts anti-osteosarcoma activity by regulating the PI3K/AKT signaling pathway

Z Ziheng Wu X Xingxing Li (Key Laboratory of Precision and Intelligent Chemistry) S Shunjie Yao H Hao Wang (Division of Quantitative Sciences, Department of Oncology Johns Hopkins University School of Medicine Baltimore Maryland USA) Y Yu Wang Y Yanchao Ding (School of Pharmaceutical Sciences, MOE Key Laboratory of Bioorganic Phosphorus Chemistry and Chemical Biology) Y Yong Hu

Article Details

Volume / Issue Vol. 1, Issue 1
Published June 10, 2026
ISSN 2045-2322
Publisher Nature Portfolio

Journal Info

Scientific Reports

Nature Portfolio

ISSN: 2045-2322 Open Access Life Sciences

Authors (7)

Z

Ziheng Wu

X

Xingxing Li

Key Laboratory of Precision and Intelligent Chemistry

S

Shunjie Yao

H

Hao Wang

Division of Quantitative Sciences, Department of Oncology Johns Hopkins University School of Medicine Baltimore Maryland USA

Y

Yu Wang

Y

Yanchao Ding

School of Pharmaceutical Sciences, MOE Key Laboratory of Bioorganic Phosphorus Chemistry and Chemical Biology

Y

Yong Hu